中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

原发性肝癌合并肝硬化患者肝切除术后人血白蛋白的应用分析

黄东海 施建设 张诚华

引用本文:
Citation:

原发性肝癌合并肝硬化患者肝切除术后人血白蛋白的应用分析

DOI: 10.3969/j.issn.1001-5256.2015.06.020
基金项目: 

南京军区重点课题资助项目(10MB018); 

详细信息
  • 中图分类号: R735.7

Usage analysis of human serum albumin in patients with liver cancer and liver cirrhosis after hepatectomy

Research funding: 

 

  • 摘要:

    目的分析肝癌合并肝硬化患者术后人血白蛋白的用法。方法将2012年1月-2014年1月收治的121例肝癌合并肝硬化接受肝切除术患者分为对照组60例和观察组61例,两组患者在常规保肝等内科治疗基础上加用人血白蛋白制剂。观察组:术后48 h内予5%人血白蛋白静脉滴注,48 h复查患者血浆白蛋白水平,若白蛋白<35 15="" 35="" 48="">0.05),而人血白蛋白用量、血浆用量、住院时间构成差异有统计学意义(P值均<0.05)。术后...

     

  • [1]XU XH,XIANG XX,LONG AH,et al.Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J].J Clin Hepatol,2013,29(3):214-216.(in Chinese)许秀华,向晓星,龙爱华,等.原发性肝癌合并与不合并肝硬化患者年龄及乙型肝炎病毒血清学特点比较[J].临床肝胆病杂志,2013,29(3):214-216.
    [2]YANG M,NING H,YE LY,et al.Rational clinical application of human serum albumin[J].China Pharm,2014,23(6):88-91.(in Chinese)杨敏,宁红,叶琳燕,等.人血白蛋白的临床合理应用[J].中国药业,2014,23(6):88-91.
    [3]YAN Y,BO T.Efficacy of terlipressin combined with albumin in treatment of hepatorenal syndrome:a report of 35 cases[J].Chin J Integr Tradit West Med Liver Dis,2012,22(6):377-378.(in Chinese)闫勇,柏涛.特利加压素联合白蛋白治疗肝肾综合征35例[J].中西医结合肝病杂志,2012,22(6):377-378.
    [4]Chinese Expert Consensus Statement Chinese Society of Liver Cancer(CSLC),Chinese Society of Clinical Oncology(CSCO),Liver Cancer Group,Chinese Society of Hepatology.Consensus on standardized diagnosis and treatment of primary liver cancer[J].J Clin Hepatol,2009,25(2):83-92.(in Chinese)中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志,2009,25(2):83-92.
    [5]CESCON M,VETRONC G,GRAZI GL,et al.Trends in perioperative outcome after hepatic resection:analysis of 1500 consecutive unstleered cases over 20 years[J].Ann Surg,2009,249(6):995-1002.
    [6]LI QL,LI JD,XU W,et al.Factors related to continual hypoproteinemia after hepatectomy for patients with hepatocellular carcinoma[J].Chin J Digest Surg,2012,11(2):151-154.(in Chinese)李权林,李敬东,徐威,等.肝癌肝切除术后持续低蛋白血症的相关因素分析[J].中华消化外科杂志,2012,11(2):151-154.
    [6]GONG CG,WANG B,ZHAN Q,et al.Analysis of incidence and influencing factors of systemic inflammatory response syndrome after hepatectomy[J].J Pharm Pract,2012,30(5):361-364.(in Chinese)龚纯贵,王彬,战旗,等.肝切除术后全身性炎症反应发生率及其影响因素分析[J].药学实践杂志,2012,30(5):361-364.
    [7]PAN AJ,LIU B.Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients[J].Chin Critical Care Med,2013,25(1):59-61.(in Chinese)潘爱军,刘宝.欧洲危重病协会关于危重患者中胶体应用的共识[J].中国危重病急救医学,2013,25(1):59-61.
    [8]SCHRAMKO AA,SUOJARANTA-YLINEN RT,KUITUNEN AH,et al.Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery:a prospective randomized trial[J].Anesth Analg,2009,108(1):30-36.
    [9]ALVAREZ B,CARBALLAL S,TURELL L,et al.Formation andreactions of sulfenic acid in human serum albumin[J].Methods Enzymol,2010,56(473):117-136.
  • 加载中
计量
  • 文章访问数:  2016
  • HTML全文浏览量:  23
  • PDF下载量:  479
  • 被引次数: 0
出版历程
  • 出版日期:  2015-06-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回